Six Elsevier platforms, from drug data to research analytics
The Elsevier Reaxys research bundle is the widest of the Elsevier packages: Embase anchors it with more than 32 million records drawn from over 8,500 biomedical journals and exhaustive coverage of drug literature, adverse effects and clinical studies, and Reaxys, ScienceDirect, Scopus, SciVal and Engineering Village complete the set.
-
6platforms
-
32M+records
-
8,500+journals
Inside this resource
Embase at 32 million records
The bibliographic and pharmacological core holds over 32 million records from more than 8,500 biomedical journals, with exhaustive coverage of drug literature, adverse effects and clinical studies — the depth pharmacovigilance work demands.
Chemistry and literature in the Elsevier Reaxys research bundle
Reaxys brings chemical reaction and substance data, while ScienceDirect supplies peer-reviewed full text across disciplines — pairing the chemistry with the published science that surrounds it.
Citations, analytics and engineering
Scopus provides the citation index, SciVal turns that data into research analytics, and Engineering Village extends the reach into engineering literature, making this a package for a department rather than a single reader.
Who this serves
- Pharmacology researchers — Embase depth plus Reaxys chemistry in one subscription.
- Research groups — literature, citations and analytics across six platforms.
- Drug-safety teams — exhaustive adverse-effect and clinical-study coverage.
Before you buy
What is included?
Embase, Reaxys, ScienceDirect, Scopus, SciVal and Engineering Village — six platforms in one order.
How large is Embase here?
More than 32 million records from over 8,500 biomedical journals.
The chart
| Format | Multi-platform bundle (6-in-1) |
|---|---|
| Includes | Embase · Reaxys · ScienceDirect · Scopus · SciVal · Engineering Village |
| Embase scale | 32M+ records |
| Publisher | Elsevier |
| Department | Pharmacology |
| Delivery | Emailed once your order is verified |




T. Fujimoto –
Enormous package. Engineering Village is peripheral for me but everything else gets used weekly.
Dr. Klaus M. –
Embase at 32 million records plus Reaxys for the chemistry covers our whole drug-discovery workflow. Six platforms for one price is extraordinary.
med_chem_ana –
Reaxys alone usually costs more than this. Adding Scopus and SciVal made it an easy decision for the group.
Dr. Sara L. –
Adverse-effect searching in Embase is exhaustive. Exactly what pharmacovigilance needs.
lab_dmitri –
Excellent value bundle. It is a lot of platforms to learn, so expect a ramp-up, but the depth is genuinely there.